Bavarian Nordic A/S (OTCMKTS:BVNRY) Short Interest Update

Bavarian Nordic A/S (OTCMKTS:BVNRY) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 4,100 shares, a drop of 33.9% from the November 30th total of 6,200 shares. Based on an average daily trading volume, of 34,900 shares, the short-interest ratio is currently 0.1 days.

Bavarian Nordic A/S Price Performance

Shares of OTCMKTS BVNRY traded up $0.26 during midday trading on Friday, reaching $8.98. The company’s stock had a trading volume of 8,435 shares, compared to its average volume of 32,110. The stock has a market capitalization of $2.12 billion, a P/E ratio of 13.01 and a beta of 1.65. The firm has a 50 day moving average price of $9.43 and a 200-day moving average price of $10.00. Bavarian Nordic A/S has a 12-month low of $6.86 and a 12-month high of $14.60.

About Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.